News

Singapore, September 2023 – A research team at Duke-NUS Medical School in Singapore has developed a T cell therapy that could play an important role in treating cancer recurrences after liver transplants. The new treatment, called IDRA HBV-TCR*, is able to target and...

Frankfurt, June 2023 – X-ZELL, a pioneering company in the field of next-generation cytology, is proud to announce a strategic collaboration with the Medizinisches Versorgungszentrum für Pathologie, Zytodiagnostik und Molekularpathologie (MVZ) in Frankfurt, Germany, a...

Singapore, August 2022 – X-ZELL is proud to announce the appointment of Michael Tillmann as member of the company’s executive board. Drawing on more than 30 years of experience in the pharmaceutical and diagnostics industry, Mr Tillmann previously held the CEO...

Singapore, March 2022 – Singaporean medical technology specialist X-ZELL has appointed Sebastian Grote as Managing Director, effective from 1 March 2022. Grote previously served as Head of Marketing & Strategy at X-ZELL and has been with the company since 2017,...

Warsaw, October 2021 – New study data presented at the European Congress of Cytology – held from 3-6 Oct in Warsaw, Poland – confirmed that X-ZELL is able to detect tumour-associated circulating atypical cells in the blood of lung cancer patients  The dataset...

Singapore, September 2021 – X-ZELL’s widely recognised high-gradient magnetic Cell Separator (hMX™) is now available to researchers worldwide. Previously exclusive to X-ZELL, the patented system is part of the company's single-cell diagnostics platform, which is...

Singapore, August 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the formation of a new, interdisciplinary Imaging Technology division. The announcement comes on the back of a new collaboration agreement with Finnish Artificial Intelligence (AI)...

Lennestadt, February 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the opening of a new international office in Germany.  Recently voted the second-most innovative health-tech start-up in the world1, X-ZELL has developed a powerful platform...

Singapore, November 2020 – X-ZELL, a Singapore start-up specialising in early cancer detection, has announced the appointment of Claire Fives as the company’s new Head of Clinical Development. Fives recently served as Associate Director, Clinical Operations, at...

Los Angeles & Singapore, November 2020 (via Business Wire) – MedTech Innovator, the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), today announced X-ZELL as the winner of its 2020...